Skip to main content

Advertisement

Log in

Safety Analysis of a Hemostatic Powder in a Porcine Model of Acute Severe Gastric Bleeding

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Non-variceal upper gastrointestinal (UGI) bleeding is a common condition that requires prompt lifesaving therapy and traditional endoscopic treatments require high technical proficiency to perform.

Aims

This study was conducted to identify any local or systemic histopathologic effects of a hemostatic powder in a porcine model of active, severe, non-variceal UGI hemorrhage.

Methods

This prospective, non-blinded animal study was performed in accordance with Good Laboratory Practice and Animal Care and Use Guidelines. Six animals underwent gastrotomy and creation of a looped vascular bundle, which was placed into the stomach lumen. The transplanted vascular bundle was punctured with an endoscopic needle–knife to create Forrest grade Ia or Ib bleeding. The hemostatic powder was then applied until hemostasis was achieved.

Results

Initial hemostasis was achieved in all animals. Results of pre- and post-treatment coagulation studies were similar. All animals survived at least 9 days post-procedure. The hemostatic powder was not found in any local, regional, or systemic tissues. Gross and histologic analysis of systemic organs showed no infarct, particulate, or embolic effects. No gross or microscopic necropsy findings were treatment-related.

Conclusions

The hemostatic powder achieved initial hemostasis (even in animals with spurting arterial bleeding) with no bowel obstruction or unintended luminal effects, no local or regional particulate effects, no systemic embolic effects, and no systemic coagulopathic effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Albeldawi M, Qadeer MA, Vargo JJ. Managing acute upper GI bleeding, preventing recurrences. Cleve Clin J Med. 2010;77:131–142.

    Article  PubMed  Google Scholar 

  2. Sung JJ, Luo D, Wu JC, et al. Early clinical experience of the safety and effectiveness of Hemospray in achieving hemostasis in patients with acute peptic ulcer bleeding. Endoscopy. 2011;43:291–295.

    Article  PubMed  CAS  Google Scholar 

  3. Kheirabadi BS, Mace JE, Terrazas IB, et al. Safety evaluation of new hemostatic agents, smectite granules, and kaolin-coated gauze in a vascular injury wound model in swine. J Trauma. 2010;68:269–278.

    Article  PubMed  CAS  Google Scholar 

  4. Gerlach T, Grayson JK, Pichakron KO, et al. Preliminary study of the effects of smectite granules (WoundStat) on vascular repair and wound healing in a swine survival model. J Trauma. 2010;69:1203–1209.

    Article  PubMed  CAS  Google Scholar 

  5. FDA 21 CFR Part 58, Good Laboratory Practice for Nonclinical Laboratory Studies.

  6. Japanese GLP Ministerial Ordinance. No 37, 2005.

  7. OCED ENV/MC/CHEM 98(17), OECD Environmental Health and Safety Publications, 1998.

  8. Guide for the Care and Use of Laboratory Animals. 8 th ed. The National Academies Press, 2011.

  9. Alexander S, Korman MG, Sievert W. Cyanoacrylate in the treatment of gastric varices complicated by multiple pulmonary emboli. Intern Med J. 2006;36:462–465.

    Article  PubMed  CAS  Google Scholar 

  10. Gallet B, Zemour G, Saudemont JP, Renard P, Hillion ML, Hiltgen M. Echocardiographic demonstration of intracardiac glue after endoscopic obturation of gastroesophageal varices. J Am Soc Echocardiogr. 1995;8:759–761.

    Article  PubMed  CAS  Google Scholar 

  11. Tan YM, Goh KL, Kamarulzaman A, et al. Multiple systemic embolisms with septicemia after gastric variceal obliteration with cyanoacrylate. Gastrointest Endosc. 2002;55:276–278.

    Article  PubMed  Google Scholar 

  12. Sadio A, Peixoto P, Cancela E, et al. Intramural hematoma: a rare complication of endoscopic injection therapy for bleeding peptic ulcers. Endoscopy. 2011;43:E141–E142.

    Article  PubMed  Google Scholar 

  13. Brearley S, Hawker PC, Dykes PW, Keighley MR. Per-endoscopic bipolar diathermy coagulation of visible vessels using a 3.2 mm probe—a randomised clinical trial. Endoscopy. 1987;19:160–163.

    Article  PubMed  CAS  Google Scholar 

  14. Ishiguro T, Nagawa H. Inadvertent endoscopic application of a hemoclip to the splenic artery through a perforated gastric ulcer. Gastrointest Endosc. 2001;53:378–379.

    PubMed  CAS  Google Scholar 

  15. Giday SA, Kim Y, Krishnamurty DM, et al. Long-term randomized controlled trial of a novel nanopowder hemostatic agent (TC-325) for control of severe arterial upper gastrointestinal bleeding in a porcine model. Endoscopy. 2011;43:296–299.

    Article  PubMed  CAS  Google Scholar 

  16. Chen YI, Barkun AN, Soulellis C, Mayrand S, Ghali P. Use of the endoscopically applied hemostatic powder TC-325 in cancer-related upper GI hemorrhage: preliminary experience (with video). Gastrointest Endosc. 2012;75:1278–1281.

    Article  PubMed  Google Scholar 

  17. Leblanc S, Vienne A, Dhooge M, Coriat R, Chaussade S, Prat F. Early experience with a novel hemostatic powder used to treat upper GI bleeding related to malignancies or after therapeutic interventions (with videos). Gastrointest Endosc. (Epub ahead of print). doi:10.1016/j.gie.2013.03.006.

  18. Holster IL, Kuipers EJ, Tjwa ET. Hemospray in the treatment of upper gastrointestinal hemorrhage in patients on antithrombotic therapy. Endoscopy. 2013;45:63–66.

    Article  PubMed  CAS  Google Scholar 

  19. Holster IL, Poley JW, Kuipers EJ, Tjwa ET. Controlling gastric variceal bleeding with endoscopically applied hemostatic powder (Hemospray™). J Hepatol. 2012;57:1397–1398.

    Article  PubMed  Google Scholar 

  20. Stanley AJ, Smith LA, Morris AJ. Use of hemostatic powder (Hemospray) in the management of refractory gastric variceal hemorrhage. Endoscopy. 2013;45:E86–E87.

    Article  PubMed  Google Scholar 

  21. Soulellis CA, Carpentier S, Chen YI, Fallone CA, Barkun AN. Lower GI hemorrhage controlled with endoscopically applied TC-325 (with videos). Gastrointest Endosc. 2013;77:504–507.

    Article  PubMed  Google Scholar 

  22. Moosavi S, Chen YI, Barkun AN. TC-325 application leading to transient obstruction of a post-sphincterotomy biliary orifice. Endoscopy. 2013;45:E130.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

The authors thank William Voorhees, PhD, of MED Institute, Inc. (a contract research organization and Cook Group Company) for critical manuscript review.

Conflict of interest

Dr. Samuel Giday is a consultant for Cook Medical. Drs. Van Alstine and Van Vleet are independent contractors for MED Institute, Inc (a Cook Group company), although Dr. Van Vleet passed away prior to manuscript submission. Richard Ducharme was a full-time employee of Cook Endoscopy (a Cook Group company) at the time of the study; he is currently employed elsewhere. The following authors are full-time employees of MED Institute, Inc: Eric Brandner, Madalina Florea, Krystal Johnston, Jose Negron-Garcia, and Kimberly Ringenberger. The study was funded by Cook Medical, the manufacturer of the hemostatic powder.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Samuel Giday.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Giday, S., Van Alstine, W., Van Vleet, J. et al. Safety Analysis of a Hemostatic Powder in a Porcine Model of Acute Severe Gastric Bleeding. Dig Dis Sci 58, 3422–3428 (2013). https://doi.org/10.1007/s10620-013-2846-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-013-2846-z

Keywords

Navigation